Breast Cancer Cases, Deaths Expected To Rise Worldwide
via HealthDayTUESDAY, March 3, 2026 — Breast cancer deaths are expected to continue rising over the next decade and a half, driven in part by unhealthy lifestyle choices, a new study says.
Worldwide, breast cancer deaths are projected to increase by 44%, rising to nearly 1.4 million by 2050 from 764,000 in 2023, researchers recently reported in The Lancet Oncology.
Breast cancer cases are also expected to mount, rising by one-third to more than 3.5 million in 2050 from 2.3 million in 2023, researchers found.
They said these increases will occur despite advancements in detecting and treating breast cancers, with cases and deaths rising in particular among lower-income countries.
“Breast cancer continues to take a profound toll on women’s lives and communities,” said lead researcher Kayleigh Bhangdia, a research scientist at the Institute for Health Metrics and Evaluation at the University of Washington in Seattle.
“While those in high-income countries typically benefit from screening and more timely diagnosis and comprehensive treatment strategies, the mounting burden of breast cancer is shifting to low- and lower middle-income countries where individuals often face later-stage diagnosis, more limited access to quality care and higher death rates that are threatening to eclipse progress in women’s health,” Bhangdia said in a news release.
However, researchers also found that maintaining a healthy lifestyle – not smoking, lowering red meat consumption, exercising and having a healthy weight – could prevent more than a quarter of healthy years lost globally to illness and breast cancer death.
For the new study, researchers analyzed breast cancer data covering 204 countries and territories from 1990 to 2023, and used that to project cancer cases and deaths out to 2050.
In 2023, 28% of the global breast cancer burden was linked to six addressable risk factors: red meat (11%); smoking (8%); high blood sugar (6%); high body mass index (4%); drinking (2%); and lack of exercise (2%) Body mass index (BMI) is an estimate of body fat based on height and weight.
“With more than a quarter of the global breast cancer burden linked to six modifiable lifestyle changes, there are tremendous opportunities to alter the trajectory of breast cancer risk for the next generation,” co-senior author Marie Ng said in a news release. She’s an associate professor at the National University of Singapore.
“Targeting known risk factors through public health policies and making healthier choices more accessible, while working with individuals to take action to reduce obesity and high blood sugar, is crucial to halting the rise in breast cancers worldwide,” she said.
Researchers also found a disturbing increase in breast cancers among younger women.
Since 1990, rates of new cases have risen by 29% among 20- to 54-year-old women, while rates among older women have not changed substantially.
Worldwide, three times as many new breast cancer cases were diagnosed in women 55 or older compared to women between 20 to 54, results showed.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-03-04 01:42
Read more
- NIH Halts Arm of Clinical Trial Evaluating a Potential Stroke Treatment
- FDA Approves Novo Nordisk's Sogroya as the First and Only Once-Weekly, Long-Acting Growth Hormone for Three Additional Pediatric Indications
- Pfizer’s Ultra-Long-Acting Injectable GLP-1 RA PF’3944 Shows Robust and Continued Weight Loss with Monthly Dosing in Phase 2b Trial
- Worsening of Overactive Bladder Seen in Patients Undergoing Gender-Affirming Vaginoplasty
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions